MD Medical Investments : Group has submitted documents for the registration in Russia

MD Medical Group Investments Plc ("MD Medical Group," "MDMG," the "Group" or the "Company" - MOEX: MDMG), a leading Russian private healthcare provider, informs about the redomiciliation status.

The Company has received the official consent of the Cyprus Registrar to continue MD Medical's operations outside the Republic of Cyprus and submitted a set of documents for the Company's state registration in the Special Administrative Region ("SAR") on Oktyabrsky Island in Russia's Kaliningrad Region as an International Public Joint-Stock Company MD Medical Group Investments (the short name: MD Medical Group IPJSC, hereinafter referred to as "IPJSC"). The process is regulated by the Federal Law "On International Companies".

The SAR Management Company is to review the documents and submit them to the Bank of Russia to register the Company's share issue and prospectus approved by the Company's Board of Directors on 26 March 2024. After that, the Russian registration authority carries out state registration of the Company in the Russian Federation. The approximate term of the process, including state registration of the Company in Russia, is 35 working days.

After the Company is registered in the Russian Federation, the Russian registrar starts maintaining the Company's shareholder register, GDRs will be exchanged for the Company's shares on the list of securities publicly traded on the Moscow Exchange, and measures will be taken to convert GDRs into the Company's shares.

Answers to the most common questions related to the procedure of conversion of MD Medical's GDRs into IPJSC's shares will be available as soon as possible in the Company's updated Q&A: https://www.mcclinics.com/investors/qa/.

***

About MD Medical Group

MD Medical Group is a leading provider in the Russian private healthcare service market. The Company manages 55 modern healthcare facilities, including 11 hospitals and 44 out-patient clinics in 27 regions of Russia. In 2023, MD Medical Group's revenue amounted to RUB 27.6 bln while EBITDA was RUB 9.2 bln. The Company's GDRs are traded on Moscow Exchange (MOEX: MDMG).